Prevalence and prognostic impact of kidney disease on heart failure patients

被引:65
|
作者
Lofman, Ida [1 ,2 ]
Szummer, Karolina [1 ,2 ]
Hagerman, Inger [1 ,2 ]
Dahlstrom, Ulf [3 ]
Lund, Lars H. [2 ,4 ]
Jernberg, Tomas [1 ,2 ]
机构
[1] Sect Cardiol Huddinge, Dept Med, Huddinge, Sweden
[2] Karolinska Inst, Karolinska Univ Hosp, Stockholm, Sweden
[3] Linkoping Univ Hosp, Dept Med & Hlth Sci, Dept Cardiol, Linkoping, Sweden
[4] Sect Cardiol, Dept Med, Solna, Sweden
来源
OPEN HEART | 2016年 / 3卷 / 01期
关键词
D O I
10.1136/openhrt-2015-000324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim was to determine the prevalence of different degrees of kidney dysfunction and to examine their association with short-term and long-term outcomes in a large unselected contemporary heart failure population and some of its subgroups. We examined to what extent the different cardiac conditions and their severity contribute to the prognostic value of kidney dysfunction in heart failure. Design: We studied 47 716 patients in the Swedish Heart Failure Registry. Patients were divided into five renal function strata based on estimated glomerular filtration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration equation. The adjusted association between kidney function and outcome was examined by Cox regression. Results: 51% of the patients had eGFR <60 mL/min/1.73 m(2) and 11% had eGFR <30. There was increasing mortality with decreasing kidney function regardless of age, presence of diabetes, New York Heart Association NYHA class, duration of heart failure and haemoglobin levels. The risk HR (95% CI) persisted after adjusting for differences in baseline characteristics, severity of heart disease, and medical treatment: eGFR 60-89: 0.86 (0.79 to 0.95); eGFR 30-59: 1.13 (1.03 to 1.24); eGFR 15-29: 1.85 (1.67 to 2.07); and eGFR <15: 2.96 ([2.53 to -3.47)], compared with eGFR >= 90. Conclusions: Kidney dysfunction is common and strongly associated with short-term and long-term outcomes in patients with heart failure. This strong association was evident in all age groups, regardless of NYHA class, duration of heart failure, haemoglobin level, and presence/absence of diabetes mellitus. After adjusting for differences in baseline data, aetiology and severity of heart disease and treatment, the strong association remained.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [21] Prevalence and Prognostic Impact of Diastolic Dysfunction in Patients with Chronic Kidney Disease on Hemodialysis
    Barberato, Silvio H.
    Bucharles, Sergio G. E.
    Sousa, Admar M.
    Costantini, Costantino O.
    Costantini, Costantino R. F.
    Pecoits-Filho, Roberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (04) : 457 - 462
  • [22] Heart failure in patients with kidney disease
    Tuegel, Courtney
    Bansal, Nisha
    HEART, 2017, 103 (23) : 1848 - 1853
  • [23] Prevalence and prognostic impact of subclinical pulmonary congestion at discharge in patients with acute heart failure
    Rivas-Lasarte, Mercedes
    Maestro, Alba
    Fernandez-Martinez, Juan
    Lopez-Lopez, Laura
    Sole-Gonzalez, Eduard
    Vives-Borras, Miquel
    Montero, Santiago
    Mesado, Nuria
    Pirla, Maria J.
    Mirabet, Sonia
    Fluvia, Paula
    Brossa, Vicens
    Sionis, Alessandro
    Roig, Eulalia
    Cinca, Juan
    Alvarez-Garcia, Jesus
    ESC HEART FAILURE, 2020, 7 (05): : 2621 - 2628
  • [24] Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter-defibrillator
    Bruch, Christian
    Bruch, Chahrebanu
    Sindermann, Juergen
    Breithardt, Guenter
    Gradaus, Rainer
    EUROPACE, 2007, 9 (08): : 681 - 686
  • [25] Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients
    La Carrubba, Salvatore
    Antonini-Canterin, Francesco
    Fabiani, Iacopo
    Colonna, Paolo
    Pugliese, Nicola Riccardo
    Caso, Pio
    Conte, Lorenzo
    Benedetto, Frank
    Zito, Concetta
    Citro, Rodolfo
    Carerj, Scipione
    Di Bello, Vitantonio
    METABOLIC SYNDROME AND RELATED DISORDERS, 2016, 14 (03) : 187 - 194
  • [26] Prevalence and prognostic impact of QRS prolongation in patients with heart failure with normal ejection fraction
    Jurga, J.
    Edner, M.
    Jansson, A.
    Linde, C.
    Dahlstrom, U.
    Lund, L. H.
    EUROPEAN HEART JOURNAL, 2008, 29 : 772 - 772
  • [27] Prevalence and prognostic impact of somatic mutations in patients with heart failure and reduced ejection fraction
    Vazquez Andres, D. J.
    Hernandez Vicente, A.
    Diez Diez, M.
    Gomez Molina, M.
    Quintas, A.
    Vazquez, E.
    Dopazo, A.
    Asensio Lopez, M. C.
    Lax, A.
    Sanchez Perez, M. C.
    Fer, E.
    De La Barrera, J.
    Sanchez Cabo, F.
    Fuster, J. J.
    Figal, D. A. Pascual
    EUROPEAN HEART JOURNAL, 2020, 41 : 966 - 966
  • [28] Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease
    Poletti, Roberta
    Vergaro, Giuseppe
    Zyw, Luc
    Prontera, Concetta
    Passino, Claudio
    Emdin, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 711 - 715
  • [29] Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure. Data from the GISSI-Heart Failure trial.
    Canepa, M.
    Temporelli, P. L.
    Rossi, A.
    Rossi, A.
    Gonzini, L.
    Nicolosi, G. L.
    Staszewsky, L.
    Marchioli, R.
    Maggioni, A. P.
    Tavazzi, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 442 - 443
  • [30] Prevalence and implications of heart failure stages A-D in patients with chronic kidney disease
    Lauridsen, A.
    Landler, N. E.
    Olsen, F. J.
    Johansen, N. D.
    Lassen, M. C. H.
    Christensen, J.
    Christoffersen, C.
    Ballegaard, E. L. F.
    Soerensen, I. M. H.
    Bjergfelt, S. S.
    Bro, S.
    Feldt-Rasmussen, B.
    Hansen, D.
    Biering-Soerensen, T.
    EUROPEAN HEART JOURNAL, 2023, 44